DISCOUNT-ZERTIFIKAT - FRESENIUS Share Price

Certificat

DE000KH2Y121

Delayed Deutsche Boerse AG 18:41:07 23/05/2024 BST
25.78 EUR +0.27% Intraday chart for DISCOUNT-ZERTIFIKAT - FRESENIUS
Current month+1.50%
1 month+1.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
23/05/24 25.78 +0.27%
22/05/24 25.71 +0.23%
21/05/24 25.65 -0.31%
20/05/24 25.73 +0.04%
17/05/24 25.72 -0.04%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 06:41 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Citi Citi
WKN KH2Y12
ISINDE000KH2Y121
Date issued 27/01/2023
Maturity 20/06/2024 (28 Days)
Parity 1 : 1
Emission price 21.31
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 25.79
Lowest since issue 20.11

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.63 EUR
Average target price
36.72 EUR
Spread / Average Target
+32.92%
Consensus